EVELYN METZ: Open Payments
NPI 1285094045 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $212 |
| Amgen Inc. | 3 | $141 |
| Boston Scientific Corporation | 1 | $125 |
| ABIOMED | 1 | $125 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: AIRSUPRA, REPATHA, WATCHMAN FLX, PURIFIED CORTROPHIN GEL, FARXIGA, TRELEGY ELLIPTA, MOUNJARO, Rybelsus.
Industry payments across NC — which companies pay providers there.
